Bioventus BVS Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bioventus's foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bioventus's foreign currency translation gains (losses)?
- Bioventus (BVS) reported foreign currency translation gains (losses) of -$1.47M in Q1 2026.
- How has Bioventus's foreign currency translation gains (losses) changed year-over-year?
- Bioventus's foreign currency translation gains (losses) decreased by 331.9% year-over-year, from $633K to -$1.47M.
- What is the long-term trend for Bioventus's foreign currency translation gains (losses)?
- Over 3 years (2021 to 2025), Bioventus's foreign currency translation gains (losses) has grown at a 4.3% compound annual growth rate (CAGR), from -$1.59M to $1.81M.
- What does foreign currency translation gains (losses) mean?
- This metric captures the gains or losses resulting from the translation of financial statements of foreign subsidiaries from their functional currency into the reporting currency. It reflects the impact of exchange rate fluctuations on the company's international net assets. Monitoring this helps investors distinguish between operational performance and currency-driven accounting effects.